BMRN
Biomarin Pharmaceutical Inc
Price:  
84.71 
USD
Volume:  
3,023,446.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin EV/EBITDA

-53.2%
Upside

As of 2024-06-21, the EV/EBITDA ratio of Biomarin Pharmaceutical Inc (BMRN) is 54.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biomarin's latest enterprise value is 16,858.77 mil USD. Biomarin's TTM EBITDA according to its financial statements is 311.75 mil USD. Dividing these 2 quantities gives us the above Biomarin EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 17.6x - 26.5x 22.5x
Forward P/E multiples 23.4x - 33.9x 29.6x
Fair Price 24.79 - 53.71 39.66
Upside -70.7% - -36.6% -53.2%
84.71 USD
Stock Price
39.66 USD
Fair Price

Biomarin EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-20 54.08
2024-06-18 53.74
2024-06-17 54.27
2024-06-14 53.35
2024-06-13 53.79
2024-06-12 53.98
2024-06-11 53.57
2024-06-10 53.00
2024-06-07 51.63
2024-06-06 51.73
2024-06-05 51.01
2024-06-04 50.66
2024-06-03 49.02
2024-05-31 48.21
2024-05-30 47.85
2024-05-29 48.20
2024-05-28 47.82
2024-05-24 48.48
2024-05-23 48.71
2024-05-22 49.05
2024-05-21 49.59
2024-05-20 49.41
2024-05-17 49.72
2024-05-16 49.36
2024-05-15 51.45
2024-05-14 51.00
2024-05-13 51.51
2024-05-10 51.84
2024-05-09 52.26
2024-05-08 52.32
2024-05-07 52.78
2024-05-06 52.49
2024-05-03 52.70
2024-05-02 53.52
2024-05-01 53.24
2024-04-30 51.67
2024-04-29 52.51
2024-04-26 51.76
2024-04-25 52.53
2024-04-24 58.03
2024-04-23 58.56
2024-04-22 56.99
2024-04-19 56.47
2024-04-18 57.34
2024-04-17 57.59
2024-04-16 57.83
2024-04-15 58.22
2024-04-12 58.65
2024-04-11 58.19
2024-04-10 57.43